London LSE Most Active Stocks Tuesday, September 3, 2013

New Post Public Reply Private Reply Replies (0) Message Board
Polgar
London LSE Most Active Stocks Tuesday, September 3, 2013 1:43:31 PM

Symbol - Company Name - Std Dev - Last - Change - Percent - High - Low - Time
TSG.LS Trans-Siberian Gold +4.15 25.000 +2.500 +11.11% 25.000 23.000 09/02/13
CCP.LS Celtic Plc +4.05 60.000 +2.500 +4.35% 61.000 57.900 09/02/13
SAG.LS Sagentia Group Plc +3.97 136.000 +4.000 +3.03% 139.000 132.000 09/02/13
IPP.LS Ipplus Plc +3.89 22.000 +2.500 +12.82% 22.400 21.000 09/02/13
AVG.LS Avingtrans Plc +3.89 133.500 +3.500 +2.69% 136.000 133.500 09/02/13
ELR.LS Eastern Platinum Lim +3.72 4.875 +0.375 +8.33% 5.150 4.675 09/02/13
THG.LS Terrace Hill Group +3.63 23.625 +0.875 +3.85% 24.145 22.950 09/02/13
MOSB.LS Moss Bros Group Plc +3.55 68.000 +5.000 +7.94% 68.000 62.000 09/02/13
SBSB.LS Skipton Building Soc +3.52 77.000 +2.000 +2.67% 79.000 76.000 09/02/13
ISAT.LS Inmarsat Plc +3.48 732.500 +37.500 +5.40% 732.500 717.000 09/02/13
GPE.LS Graphite Enterprise +3.39 487.000 +9.000 +1.88% 489.200 479.500 09/02/13
PPH.LS Pphe Hotel Group Lim +3.38 331.500 +14.000 +4.41% 334.477 320.000 09/02/13
PCA.LS Palace Capital Plc +3.25 2.250 +0.125 +5.88% 2.250 1.750 09/02/13
CSN.LS Chesnara Plc +3.23 268.500 +6.250 +2.38% 270.000 260.806 09/02/13
SULA.LS Sula Iron & Gold Plc +3.21 3.375 +0.375 +12.50% 3.375 2.900 09/02/13
MOG.LS Mediterranean Oil +3.16 7.125 +0.375 +5.56% 7.125 6.800 09/02/13
BUR.LS Burford Capital Limi +3.14 140.000 +5.000 +3.70% 141.000 136.000 09/02/13
CAMB.LS Cambria Automobiles +3.09 32.000 +1.000 +3.23% 32.000 30.000 09/02/13
STAR.LS Starcom Plc +3.04 24.500 +5.250 +27.27% 25.400 19.750 09/02/13
RNO.LS Renold Plc +3.02 33.750 +3.375 +11.11% 33.950 29.750 09/02/13
STCM.LS Steppe Cement Ltd +3.01 36.500 +1.250 +3.55% 36.500 35.025 09/02/13
ECWO.LS Ecofin Water & Power +2.99 125.000 +5.750 +4.82% 125.269 120.683 09/02/13
BWSA.LS Bristol & West Plc +2.96 100.250 +0.500 +0.50% 102.500 100.030 09/02/13
NCYF.LS New City High Yield +2.96 61.000 +0.500 +0.83% 61.250 60.451 09/02/13
AUMP.LS Alpha UK Multi Prope +2.95 30.000 +4.500 +17.65% 33.000 26.960 09/02/13
DIVO.LS Downing Income Vct +2.95 26.000 +0.750 +2.97% 26.000 25.000 09/02/13
BQE.LS Bioquell Plc +2.91 145.000 +5.500 +3.94% 148.750 142.000 09/02/13
SDU.LS Schroder UK Growth +2.88 181.500 +4.500 +2.54% 181.500 179.000 09/02/13
TLPR.LS Tullett Prebon Plc +2.87 361.300 +19.600 +5.74% 361.700 342.500 09/02/13
NXR.LS Norcros Plc +2.72 18.000 +1.250 +7.46% 20.250 17.750 09/02/13
GDG.LS Green Dragon Gas Ltd +2.71 305.000 +17.500 +6.09% 314.900 288.950 09/02/13
LSIC.LS Lifeline Scientific +2.69 147.500 +9.500 +6.88% 150.000 144.000 09/02/13
FENR.LS Fenner Plc +2.69 360.400 +17.400 +5.07% 361.200 342.000 09/02/13
SMDS.LS Smith [Ds] Plc +2.68 270.000 +12.200 +4.73% 270.200 260.316 09/02/13
FRP.LS Fairpoint Group Plc +2.66 123.000 +3.500 +2.93% 125.000 119.500 09/02/13
IPXJ.LS Ishares III Plc +2.65 42.995 +1.140 +2.72% 43.080 42.680 09/02/13
RGS.LS Regenersis Plc +2.65 205.000 +2.500 +1.23% 207.000 201.000 09/02/13
XPXD.LS DB X-Trackers +2.63 48.200 +1.265 +2.70% 48.200 46.690 09/02/13
XGDD.LS DB X-Trackers +2.61 28.760 +0.460 +1.63% 28.760 28.450 09/02/13
IAUS.LS Ishares III Plc +2.60 30.270 +0.890 +3.03% 30.270 30.070 09/02/13
FSV.LS Fidelity Special Val +2.57 853.000 +13.000 +1.55% 860.000 848.000 09/02/13
OPM.LS 1Pm Plc +2.54 42.500 +2.500 +6.25% 44.000 40.000 09/02/13
APT.LS Axa Property Trust +2.53 40.250 +0.500 +1.26% 40.250 39.610 09/02/13
SAN.LS Santander UK Plc +2.52 116.875 +0.250 +0.21% 118.250 115.500 09/02/13
BT.A.LS Bt Group Plc +2.51 338.200 +12.900 +3.97% 340.258 329.800 09/02/13
CAPC.LS Capital & Counties +2.45 325.000 +7.300 +2.30% 328.800 318.300 09/02/13
MGAM.LS Morgan Crucible Co +2.45 305.000 +10.500 +3.57% 305.200 297.294 09/02/13
DCP.LS Diamondcorp Plc +2.43 6.125 +0.625 +11.36% 6.250 5.430 09/02/13
IEM.LS Impax Environmental +2.42 137.500 +2.250 +1.66% 137.500 135.000 09/02/13
EUMV.LS Ossiam Lux +2.41 120.885 +1.490 +1.25% 120.885 120.470 09/02/13
SKS.LS Shanks Group Plc +2.38 95.750 +2.000 +2.13% 95.750 94.000 09/02/13
IDAP.LS Ishares Plc +2.38 32.005 +0.600 +1.91% 32.005 31.930 09/02/13
PZC.LS Pz Cussons Plc +2.37 412.300 +11.300 +2.82% 414.000 405.200 09/02/13
HGG.LS Henderson Group Plc +2.36 174.300 +9.300 +5.64% 174.900 168.500 09/02/13
TEIF.LS Tamar European Indus +2.36 30.250 +0.375 +1.26% 31.030 30.250 09/02/13
PTEC.LS Playtech Limited +2.36 693.000 +16.000 +2.36% 700.000 677.500 09/02/13
TALK.LS Talktalk Telecom Gro +2.36 248.000 +9.500 +3.98% 251.200 238.200 09/02/13
CUP.LS Cupid Plc +2.35 67.000 +4.000 +6.35% 67.000 64.000 09/02/13
IUKD.LS Ishares Plc +2.35 865.000 +19.750 +2.34% 865.000 852.750 09/02/13
IMEA.LS Ishares III Plc +2.35 34.920 +0.670 +1.96% 34.920 34.350 09/02/13
VDPX.LS Vanguard Funds Plc +2.35 23.730 +0.530 +2.28% 23.790 23.730 09/02/13
UKDV.LS SSGA SPDR Etfs Europ +2.34 12.640 +0.220 +1.77% 12.660 12.536 09/02/13
INCH.LS Inchcape Plc +2.32 613.000 +24.000 +4.07% 614.500 594.500 09/02/13
BIOM.LS Biome Technologies +2.31 110.000 +15.000 +15.79% 114.500 98.000 09/02/13
CZA.LS Coal Of Africa Limit +2.28 8.625 +1.025 +13.49% 8.742 7.750 09/02/13
IWDE.LS Ishares V Public Lim +2.25 33.045 +0.470 +1.44% 33.045 32.680 09/02/13
IUKP.LS Ishares II Plc +2.24 481.400 +9.800 +2.08% 481.400 470.000 09/02/13
JPI.LS Jpmorgan Income & +2.24 87.250 +0.250 +0.29% 88.300 85.950 09/02/13
EDG.LS Edge Resources Inc +2.24 7.875 +0.750 +10.53% 8.000 7.450 09/02/13
HSL.LS Henderson Smaller +2.23 507.000 +9.000 +1.81% 507.000 498.000 09/02/13
CAMK.LS Camkids Group Plc +2.22 119.000 +4.000 +3.48% 119.000 115.100 09/02/13
CGNR.LS Conroy Gold & Natura +2.21 2.300 +0.175 +8.24% 2.510 2.125 09/02/13
BBA.LS Bba Aviation Plc +2.21 317.000 +9.100 +2.96% 319.149 308.000 09/02/13
CWC.LS Cable & Wireless Com +2.20 40.180 +1.570 +4.07% 40.630 38.590 09/02/13
LAND.LS Land Securities Grou +2.19 908.500 +25.500 +2.89% 911.000 892.000 09/02/13
HSBR.LS HSBC Etfs Plc +2.18 22.120 +0.595 +2.76% 22.270 22.120 09/02/13
IDFX.LS Ishares Plc +2.17 103.330 +3.615 +3.63% 103.330 99.480 09/02/13
HMCD.LS HSBC Etfs Plc +2.17 5.963 +0.165 +2.85% 5.977 5.910 09/02/13
IDAR.LS Ishares II Plc +2.16 24.245 +0.375 +1.57% 24.245 23.870 09/02/13
TCY.LS Telecity Group Plc +2.16 843.000 +23.500 +2.87% 846.000 822.641 09/02/13
HMWD.LS HSBC Etfs Plc +2.15 14.950 +0.200 +1.36% 14.960 14.950 09/02/13
SL..LS Standard Life Plc +2.14 343.500 +12.300 +3.71% 344.900 333.000 09/02/13
MXCS.LS Source Markets Publi +2.14 35.440 +0.970 +2.81% 35.440 34.840 09/02/13
MVOL.LS Ishares Vi Plc (The +2.14 27.750 +0.280 +1.02% 27.780 27.750 09/02/13
IWDA.LS Ishares III Plc +2.13 35.150 +0.460 +1.33% 35.150 35.130 09/02/13
CSWD.LS CS ETF [Ie] Plc +2.13 120.385 +1.625 +1.37% 120.590 120.385 09/02/13
XMWD.LS DB X-Trackers +2.12 38.180 +0.500 +1.33% 38.180 37.640 09/02/13
HAYT.LS Hayward Tyler Group +2.12 46.000 +2.500 +5.75% 47.950 44.000 09/02/13
IRON.LS Ironveld Plc +2.12 10.500 +0.750 +7.69% 10.750 9.670 09/02/13
PDL.LS Petra Diamonds Limit +2.11 124.000 +3.900 +3.25% 125.700 123.000 09/02/13
CWD.LS Countrywide Plc +2.11 576.000 +26.000 +4.73% 577.000 550.000 09/02/13
MXWO.LS Source Markets Publi +2.11 37.910 +0.495 +1.32% 37.910 37.710 09/02/13
ACWD.LS SSGA SPDR Etfs Europ +2.10 84.055 +1.095 +1.32% 84.170 83.590 09/02/13
ISAC.LS Ishares V Public Lim +2.10 32.050 +0.435 +1.38% 32.050 31.990 09/02/13
HLMA.LS Halma Plc +2.10 562.000 +15.500 +2.84% 569.500 552.000 09/02/13
IAP.LS Icap Plc +2.09 378.500 +11.100 +3.02% 380.300 369.300 09/02/13
KGF.LS Kingfisher Plc +2.09 395.200 +10.200 +2.65% 395.500 388.200 09/02/13
CTG.LS Christie Group Plc +2.07 76.000 +1.500 +2.01% 79.000 76.000 09/02/13
IDWR.LS Ishares Plc +2.06 31.570 +0.430 +1.38% 31.600 31.360 09/02/13
RPC.LS Rpc Group Plc +2.06 461.900 +12.600 +2.80% 469.600 455.400 09/02/13
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading